Prophylaxis of Deep Vein Thrombosis Following Total Hip Arthroplasty

PHASE4CompletedINTERVENTIONAL

Enrollment

639

Participants

Timeline

Start Date

January 31, 2012

Primary Completion Date

January 31, 2013

Study Completion Date

January 31, 2013

Conditions

Osteoarthritis, HipFemur Head NecrosisFemoral Neck Fractures

Interventions

DRUG

Rivaroxaban

Rivaroxaban was taken orally in a dosage of 10mg once daily

DRUG

Enoxaparin

Enoxaparin was injected subcutaneously in a dosage of 40mg once daily

OTHER

Normal saline

subcutaneous injection of 1 cc of normal saline once daily

All Listed Sponsors

lead

Samsung Medical Center

OTHER

NCT02379663 - Prophylaxis of Deep Vein Thrombosis Following Total Hip Arthroplasty | Biotech Hunter | Biotech Hunter